Lannett Company, Inc. LCI today said that the U.S. Food and Drug Administration (FDA) recently completed an inspection of the company's manufacturing facility in Philadelphia, Pennsylvania and Cody, Wyoming.
The inspections concluded with “minor” observations, seven at the company's facilities in Philadelphia and five at Lannett's wholly owned subsidiary, Cody Laboratories (Cody), a manufacturer/supplier of pain management pharmaceutical products.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in